Colorectal Cancer Screening Using Stool DNA-based SDC2 Methylation Test

NACompletedINTERVENTIONAL
Enrollment

1,210

Participants

Timeline

Start Date

June 7, 2020

Primary Completion Date

January 10, 2022

Study Completion Date

January 10, 2022

Conditions
Colorectal CancerColon PolypHealthy
Interventions
DIAGNOSTIC_TEST

Earlytect Colon Cancer

A diagnostic device measuring syndecan 2 methylation status in stool DNA to detect colorectal cancer

Trial Locations (8)

16247

St. Vincent's Hospital, The Catholic University of Korea, Suwon

Unknown

Busan Hangun Hospital, Busan

Koo Hospital, Daegu

Dea Hang Hospital, Seoul

Eunpyeong St. Mary's Hospital, Seoul

Seoul Songdo Hospital, Seoul

03722

Severance Hospital, Yonsei University College of Medicine, Seoul

05278

Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul

All Listed Sponsors
collaborator

Genomictree, Inc.

INDUSTRY

lead

Kyung Hee University Hospital at Gangdong

OTHER

NCT04304131 - Colorectal Cancer Screening Using Stool DNA-based SDC2 Methylation Test | Biotech Hunter | Biotech Hunter